MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.64
+0.33 (2.92%)
At close: Jun 26, 2026, 4:00 PM EDT
12.02
+0.38 (3.26%)
After-hours: Jun 26, 2026, 6:58 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $57.99 million as of June 26, 2026. Its market cap has increased by 91.69% in one year.
Market Cap
57.99M
Enterprise Value
48.46M
1-Year Change
91.69%
Ranking
Category
Stock Price
$11.64
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $57.99M, a decrease of -84.99%. That is a compound annual growth rate of -33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 57.99M | 10.79% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 62.74M |
| PMV Pharmaceuticals | 61.33M |
| Veraxa Biotech AG | 59.26M |
| Boundless Bio | 56.38M |
| Filana Therapeutics | 56.04M |
| TScan Therapeutics | 54.89M |
| aTyr Pharma | 54.88M |
| Xilio Therapeutics | 53.19M |